Toward universal immunofluorescence normalization for multiplex tissue imaging with UniFORM
- PMID: 40925367
- PMCID: PMC12539234
- DOI: 10.1016/j.crmeth.2025.101172
Toward universal immunofluorescence normalization for multiplex tissue imaging with UniFORM
Abstract
We present UniFORM, a non-parametric, Python-based pipeline for normalizing multiplex tissue imaging (MTI) data at both the feature and pixel levels. UniFORM employs an automated rigid landmark registration method tailored to the distributional characteristics of MTI, with UniFORM operating without prior distributional assumptions and handling both unimodal and bimodal patterns. By aligning the biologically invariant negative populations, UniFORM removes technical variation while preserving tissue-specific expression patterns in positive populations. Benchmarked on three MTI platforms, UniFORM consistently outperforms existing methods in mitigating batch effects while maintaining biological signal fidelity. This is evidenced by improved marker distribution alignment and positive population preservation, enhanced k-nearest neighbor batch effect test (kBET) and silhouette scores, and more coherent downstream analyses, such as uniform manifold approximation and projection (UMAP) visualizations and Leiden clustering. UniFORM also offers an optional guided fine-tuning mode for complex or heterogeneous datasets. While optimized for fluorescence-based MTI, its scalable design supports broad applications for MTI data normalization, enabling accurate and biologically meaningful interpretations.
Keywords: CP: Computational biology; CP: Imaging; batch correction; multiplex tissue imaging; normalization.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare the following competing interests: G.B.M. is a science advisory board (SAB) member or consultant for Amphista, Astex, AstraZeneca, BlueDot, Chrysalis Biotechnology, Ellipses Pharma, GSK, ImmunoMet, Infinity, Ionis, Leapfrog Bio, Lilly, Medacorp, Nanostring, Nuvectis, PDX Pharmaceuticals, Qureator, Roche, SignalChem Lifesciences, Tarveda, Turbine, and Zentalis Pharmaceuticals. G.B.M. has stock/options/financial relationships with BlueDot, Catena Pharmaceuticals, ImmunoMet, Nuvectis, SignalChem, Tarveda, and Turbine. G.B.M. has licensed technology as follows: an HRD assay to Myriad Genetics and DSP patents with Nanostring. G.B.M. has sponsored research with AstraZeneca.
Figures
Update of
-
UniFORM: Towards Universal ImmunoFluorescence Normalization for Multiplex Tissue Imaging.bioRxiv [Preprint]. 2025 May 14:2024.12.06.626879. doi: 10.1101/2024.12.06.626879. bioRxiv. 2025. Update in: Cell Rep Methods. 2025 Sep 15;5(9):101172. doi: 10.1016/j.crmeth.2025.101172. PMID: 39713407 Free PMC article. Updated. Preprint.
References
-
- Harms P.W., Frankel T.L., Moutafi M., Rao A., Rimm D.L., Taube J.M., Thomas D., Chan M.P., Pantanowitz L. Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists. Mod. Pathol. 2023;36 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
